• রেজিস্টার্ড চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন।
LINALIT M 2.5/850MG is indicated for the treatment and maintenance of bipolar disorder, providing effective control of manic and depressive episodes through the combined effects of lithium carbonate and sodium valproate.

Pharmacology:
This combination contains lithium carbonate, which stabilizes mood by modulating neurotransmitters and neuronal excitability, and sodium valproate, which acts as an anticonvulsant increasing GABA neurotransmission to reduce mood swings and seizures. Together, they offer enhanced mood stabilization.

Dosage:
Dosage should be individualized and titrated based on clinical response and blood levels of lithium and valproate. Typically started at low doses with gradual increases under medical supervision to avoid toxicity.

Administration:
Take orally with water, preferably after meals to reduce gastrointestinal discomfort. Regular monitoring of blood lithium and valproate levels is essential to ensure safety.

Interaction:
May interact with diuretics, NSAIDs, other anticonvulsants, and medications affecting renal or liver function. Always inform your healthcare provider about all medications and supplements being used.

Contraindications:
Contraindicated in patients with severe renal, hepatic, or cardiovascular disease, hypersensitivity to components, pregnancy, and lactation unless specifically advised by a doctor.

Side Effects:
Possible side effects include tremors, dizziness, gastrointestinal upset, weight gain, sedation, and rare but serious lithium or valproate toxicity requiring immediate medical attention.

Pregnancy & Lactation:
Both lithium and valproate can harm the fetus and pass into breast milk; use only if clearly necessary and under strict medical supervision.

Therapeutic Class:
Mood stabilizer combination; lithium salt and anticonvulsant.

Storage Conditions:
Store at room temperature away from moisture, heat, and direct sunlight. Keep out of reach of children. Do not use after expiration date.